Kenneth Krogulski - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 3, 2026
Kenneth Krogulski is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $56K. Historical track record: 4/5 stars across 184 tracked purchases.
Profile
Kenneth Krogulski is Director at CUMBERLAND PHARMACEUTICALS INC (CPIX). Krogulski has reported 14 insider filings with the SEC since 2024. The most recent filing was in March 2026.
| Role | Director |
|---|---|
| Notability | 26/100 |
Board memberships
- CUMBERLAND PHARMACEUTICALS INC
Reported roles
- Director
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★★★☆ (4/5) |
|---|---|
| Total purchases tracked | 184 |
| Purchases with forward-return data | 184 |
| 30-day win rate | 52% |
| 90-day win rate | 43% |
| Avg 5-day return | +1.46% |
| Avg 30-day return | +7.37% |
| Avg 90-day return | +47.96% |
| Best 30-day return | +121.70% |
Trading Pattern
InsiderAlpha's records for Kenneth Krogulski go back to 2024: 14 primary Form 4 filings, an average of 4.7 per year. The typical open-market purchase is $302 (184 buys totaling $56K). The largest single buy on record is $707 of CPIX in 2024. 141 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Career & Filing History
Every role Kenneth Krogulski has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Director at CUMBERLAND PHARMACEUTICALS INC (CPIX) - 14 filings, 2024 to 2026
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-20 | CPIX | CUMBERLAND PHARMACEUTICALS INC | A - Grant or award | 4.0K | $2.80 | $11K |
| 2026-03-20 | CPIX | CUMBERLAND PHARMACEUTICALS INC | A - Grant or award | 1.8K | $2.80 | $5K |
| 2025-12-01 | CPIX | CUMBERLAND PHARMACEUTICALS INC | J - Other acquisition / disposition [10b5-1] | 124 | $2.41 | $299 |
| 2025-12-01 | CPIX | CUMBERLAND PHARMACEUTICALS INC | J - Other acquisition / disposition [10b5-1] | 124 | $2.17 | $269 |
| 2025-12-01 | CPIX | CUMBERLAND PHARMACEUTICALS INC | J - Other acquisition / disposition [10b5-1] | 124 | $2.21 | $274 |
| 2025-12-01 | CPIX | CUMBERLAND PHARMACEUTICALS INC | J - Other acquisition / disposition [10b5-1] | 124 | $2.10 | $260 |
| 2025-12-01 | CPIX | CUMBERLAND PHARMACEUTICALS INC | J - Other acquisition / disposition [10b5-1] | 117 | $1.96 | $229 |
| 2025-12-01 | CPIX | CUMBERLAND PHARMACEUTICALS INC | J - Other acquisition / disposition [10b5-1] | 117 | $1.99 | $233 |
| 2025-12-01 | CPIX | CUMBERLAND PHARMACEUTICALS INC | J - Other acquisition / disposition [10b5-1] | 117 | $2.01 | $235 |
| 2025-12-01 | CPIX | CUMBERLAND PHARMACEUTICALS INC | J - Other acquisition / disposition [10b5-1] | 117 | $1.98 | $232 |
| 2025-12-01 | CPIX | CUMBERLAND PHARMACEUTICALS INC | J - Other acquisition / disposition [10b5-1] | 117 | $2.17 | $254 |
| 2025-12-01 | CPIX | CUMBERLAND PHARMACEUTICALS INC | J - Other acquisition / disposition [10b5-1] | 110 | $2.15 | $236 |
| 2025-12-01 | CPIX | CUMBERLAND PHARMACEUTICALS INC | J - Other acquisition / disposition [10b5-1] | 110 | $2.17 | $239 |
| 2025-12-01 | CPIX | CUMBERLAND PHARMACEUTICALS INC | J - Other acquisition / disposition [10b5-1] | 110 | $1.99 | $219 |
| 2025-12-01 | CPIX | CUMBERLAND PHARMACEUTICALS INC | J - Other acquisition / disposition [10b5-1] | 110 | $2.06 | $227 |
| 2025-12-01 | CPIX | CUMBERLAND PHARMACEUTICALS INC | J - Other acquisition / disposition [10b5-1] | 110 | $2.11 | $232 |
| 2025-12-01 | CPIX | CUMBERLAND PHARMACEUTICALS INC | J - Other acquisition / disposition [10b5-1] | 96 | $2.19 | $210 |
| 2025-12-01 | CPIX | CUMBERLAND PHARMACEUTICALS INC | J - Other acquisition / disposition [10b5-1] | 96 | $2.27 | $218 |
| 2025-12-01 | CPIX | CUMBERLAND PHARMACEUTICALS INC | J - Other acquisition / disposition [10b5-1] | 68 | $2.53 | $172 |
| 2025-12-01 | CPIX | CUMBERLAND PHARMACEUTICALS INC | J - Other acquisition / disposition [10b5-1] | 68 | $2.82 | $192 |
Most Active Insiders Right Now
Kenneth Krogulski has no recent co-filers at the same companies, so here are the insiders with the largest open-market activity across the market in the last 90 days.
- MetLife Investment Management, LLC - $1600000.00B of FINS open-market activity in the last 90 days
- Magnetar Financial LLC - $16357.48B of CRWV open-market activity in the last 90 days
- Marianne Okland - $18.46B of STNG open-market activity in the last 90 days
- VisionWave Holdings, Inc. - $14.13B of SVRE open-market activity in the last 90 days
- Vanessa Allen Sutherland - $7.44B of PSX open-market activity in the last 90 days
- AI Alpine (Luxembourg) S.a.r.l. - $2.69B of INIO open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- James M. Kilts
- Richard D. Kinder
- Steven B. Klinsky
- Adam Koppel
- L1 Capital Pty Ltd
- LAZARUS ENERGY HOLDINGS, LLC
- Sang Young Lee
- Sam Levinson
Frequently Asked Questions
Who is Kenneth Krogulski?
Kenneth Krogulski is Director at CUMBERLAND PHARMACEUTICALS INC (CPIX). Krogulski has reported 14 insider filings with the SEC since 2024. The most recent filing was in March 2026.…
Has Kenneth Krogulski been buying or selling stock?
Recorded transactions: 184 open-market purchases ($56K) and 0 open-market sales across all tracked filings.
How accurate is Kenneth Krogulski's historical track record?
Across 184 tracked purchases, Kenneth Krogulski averaged +7.4% avg 30-day return with a 52% 30-day win rate. InsiderAlpha rates the track record at 4/5 stars.
Where can I see all of Kenneth Krogulski's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Kenneth Krogulski profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.